ArticleThe Journal of infectious diseases2026
Robust COVID-19 Mortality Risk Assessment: Validation of a Two-Step Algorithm From the National COVID Cohort Collaborative.
Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study introduces and validates a 2-step algorithm for assessing coronavirus disease 2019 (COVID-19) mortality risk, leveraging data from over 7 million COVID-19 cases in the National COVID Cohort Collaborative (N3C). The original algorithm stratifies patients into risk categories based on routine clinical metrics and was initially tested across diverse cohorts from multiple institutions, demonstrating strong predictive performance. Further validation of this algorithm on 2.4 million valid N3C COVID-19 records, including a subset of 768 957 with complete data, yielded a C-statistic exceeding 0.85. The algorithm adapts effectively to evolving mortality trends, particularly during the Omicron variant surge. Comparative analyses of full and imputed datasets underscore the algorithm's robustness across varied clinical settings. Our work offers a scalable tool for pandemic management, highlighting the critical role of data-informed approaches in public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.